1. Home
  2. MLEC vs IGC Comparison

MLEC vs IGC Comparison

Compare MLEC & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLEC
  • IGC
  • Stock Information
  • Founded
  • MLEC 2008
  • IGC 2005
  • Country
  • MLEC Luxembourg
  • IGC United States
  • Employees
  • MLEC N/A
  • IGC N/A
  • Industry
  • MLEC Blank Checks
  • IGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLEC Finance
  • IGC Health Care
  • Exchange
  • MLEC Nasdaq
  • IGC Nasdaq
  • Market Cap
  • MLEC 23.9M
  • IGC 29.4M
  • IPO Year
  • MLEC N/A
  • IGC N/A
  • Fundamental
  • Price
  • MLEC $0.56
  • IGC $0.30
  • Analyst Decision
  • MLEC
  • IGC Strong Buy
  • Analyst Count
  • MLEC 0
  • IGC 2
  • Target Price
  • MLEC N/A
  • IGC $3.75
  • AVG Volume (30 Days)
  • MLEC 10.4K
  • IGC 374.3K
  • Earning Date
  • MLEC 03-12-2025
  • IGC 02-18-2025
  • Dividend Yield
  • MLEC N/A
  • IGC N/A
  • EPS Growth
  • MLEC N/A
  • IGC N/A
  • EPS
  • MLEC N/A
  • IGC N/A
  • Revenue
  • MLEC $5,625,124.00
  • IGC $1,183,000.00
  • Revenue This Year
  • MLEC $20.42
  • IGC N/A
  • Revenue Next Year
  • MLEC $30.00
  • IGC $13.38
  • P/E Ratio
  • MLEC N/A
  • IGC N/A
  • Revenue Growth
  • MLEC 521.53
  • IGC N/A
  • 52 Week Low
  • MLEC $0.55
  • IGC $0.27
  • 52 Week High
  • MLEC $3.25
  • IGC $0.91
  • Technical
  • Relative Strength Index (RSI)
  • MLEC 24.92
  • IGC 36.27
  • Support Level
  • MLEC $0.71
  • IGC $0.30
  • Resistance Level
  • MLEC $0.78
  • IGC $0.33
  • Average True Range (ATR)
  • MLEC 0.05
  • IGC 0.01
  • MACD
  • MLEC -0.02
  • IGC -0.00
  • Stochastic Oscillator
  • MLEC 3.14
  • IGC 2.00

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

Share on Social Networks: